NVZMY

NOVOZYMES A/S-UNSPONS ADR

$69.04 −0.36 (−0.52%)

Oct 30 4:00 PM ET · prev $69.40

Median target

🔒 Subscribers only

1 year

+15.7%

from $59.68 · Oct 31

30 days

+8.9%

from $63.42

52-week range

$52.81–71.93

−4% from high · low Mar 19

Avg volume 20D

24.8K

shares / day

Short interest

11.4K

+1986.3%

Days to cover

1.0

at average volume

New fund stakes

Q2 2026 13F · 0 exits

Congress trades

disclosed

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

X Jul 31 Short interest falls 86.5% to 3.6K
X Aug 14 Short interest falls 48.1% to 1.9K
X Aug 31 Short interest jumps 1727.7% to 34.2K
X Sep 15 Short interest falls 64.7% to 12.1K
X Sep 30 Short interest falls 95.5% to 546
X Oct 15 Short interest jumps 1986.3% to 11.4K

Signal stack

Where each data set points today.

InstitutionsMIXED

Q2 2026: 1 added (0 new), 0 trimmed or exited.
Short sellersBUILDING

Short interest +1986.3% to 11.4K shares. 1.0 days to cover.
TrendUPTREND

2% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
PNC FINANCIAL SERVICES GROUP, INC.	ADD	30	$1.9K
PNC FINANCIAL SERVICES GROUP, INC.	NEAR_EXIT	21	$1.3K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Congressional trades

NVZMY trades disclosed by members of Congress, with disclosure delay.

1 members · 0 buys / 1 sells

DateMemberType AmountDisclosed

Jun 1, 2026 Josh GottheimerDHouse Novozymes A/S SELL $1K–$15K Jul 7, 2026 +36d

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only

Recent activity

The latest filings, insider trades, analyst actions, press and options flow, newest first.

Jun 30, 2026 Inst.

PNC FINANCIAL SERVICES GROUP, · ADD

30 shares ($1.9K)

Jun 1, 2026 Congress

Josh Gottheimer sell

$1,001 - $15,000 · House

Apr 15, 2026 Short interest

FTD: NVZMY, 61,783 shares ($3.7M) failed to deliver

Settlement: 20260415, Price: $60.62, FTD Value: $3,745,285.46, NOVOZYMES NOVOZYMES B ADR (DNK

Mar 31, 2026 Inst.

PNC FINANCIAL SERVICES GROUP, · NEAR_EXIT

21 shares ($1.3K)

Short side

FINRA· Oct 15, 2026

11,391

shares short

+1986.3%

vs prior settlement

1.0

days to cover

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

Apr 15, 2026

Short interest

FTD: NVZMY, 61,783 shares ($3.7M) failed to deliver

Settlement: 20260415, Price: $60.62, FTD Value: $3,745,285.46, NOVOZYMES NOVOZYMES B ADR (DNK

Apr 14, 2026

Short interest

FTD: NVZMY, 142,141 shares ($8.6M) failed to deliver

Settlement: 20260414, Price: $60.72, FTD Value: $8,630,801.52, NOVOZYMES NOVOZYMES B ADR (DNK

Apr 8, 2026

Short interest

FTD: NVZMY, 9,057 shares ($0.6M) failed to deliver

Settlement: 20260408, Price: $61.38, FTD Value: $555,918.66, NOVOZYMES NOVOZYMES B ADR (DNK

Mar 31, 2026

Short interest

FTD: NVZMY, 91,085 shares ($5.4M) failed to deliver

Settlement: 20260331, Price: $59.75, FTD Value: $5,442,328.75, NOVOZYMES NOVOZYMES B ADR (DNK

Mar 30, 2026

Short interest

FTD: NVZMY, 673,960 shares ($39.8M) failed to deliver

Settlement: 20260330, Price: $58.98, FTD Value: $39,750,160.8, NOVOZYMES NOVOZYMES B ADR (DNK